Physiologic Pacing Registry
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03719040 |
Recruitment Status :
Recruiting
First Posted : October 25, 2018
Last Update Posted : July 16, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Bradycardia Sinus Node Dysfunction Heart Block Syncope Cardiomyopathies Ventricular Tachycardia Heart Failure | Device: Physiologic pacing device implant |
The Physiologic Pacing Registry will be conducted to gain a deeper understanding of physiologic pacing device implants and follow-up workflows, including device and programmer measurements to help inform Abbott's product and clinical data development efforts. Additionally, the registry will provide a broader understanding of the clinical utility in mapping physiologic pacing structures with the use of Abbott's EnSite Cardiac Mapping System with an electrophysiology catheter prior to device implants for those institutions where mapping is routine care prior to physiologic pacing device implant.
The registry will include patients undergoing implantation of an Abbott pacemaker, defibrillator, or a cardiac resynchronization therapy (CRT) pacemaker (CRT-P) or CRT defibrillator (CRT-D) according to the clinical site's routine care. Only patients scheduled to receive an Abbott device may be enrolled to ensure proper device data collection for future software and other physiologic pacing product development. The decision to provide physiologic pacing therapy and selection of devices for implant are at the discretion of the implanting physician. Abbott will collect data on the use of all commercially available leads and associated implant tools based on the physician's discretion as part of routine clinical practice within the registry.
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 1000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 6 Months |
Official Title: | Physiologic Pacing Registry |
Actual Study Start Date : | November 27, 2018 |
Estimated Primary Completion Date : | November 21, 2021 |
Estimated Study Completion Date : | May 21, 2022 |

- Device: Physiologic pacing device implant
An alternative and potentially more effective pacing strategy for patients with electrical conduction abnormalities is physiologic pacing. Physiologic pacing is achieved by delivering a pacing stimulus to a cardiac conduction structure, such as the bundle of His or left bundle branch (LBB) of the His-Purkinje system, with a permanent lead. Physiologic pacing activates the heart through the native His-Purkinje conduction system, thus offering the most physiologic pacing approach to correct electrical dyssynchrony. Physiologic pacing has emerged as a feasible and safe alternative to pacemaker therapy and CRT with clinical and electrophysiological advantages.
- Physiologic pacing device implant characteristics [ Time Frame: During procedure ]Data will be collected to characterize the workflow, success, and complications associated with standard-of-care HBP implants in patients indicated for a pacemaker, defibrillator, or CRT device. Data will be compared with and without the use of the EnSite Precision Mapping System used according to each site's routine care.
- Physiologic pacing device implant follow-up characteristics [ Time Frame: 6 Months ]Data will be collected to characterize the workflow, device system electrical performance and programming, and adverse events associated with HBP implants.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Scheduled for implantation of an Abbott pacemaker, defibrillator, or CRT-P/D device with any commercially available pacing lead as part of a physiologic pacing procedure according to the clinical site's routine care.
- At least 18 years of age.
- Willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
- Provided written informed consent prior to any registry-related procedures.
Exclusion Criteria:
- History of tricuspid valve repair or replacement.
- Currently participating in another clinical study with an active treatment arm and belong to the active arm
- Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results.
- Chronic physiologic pacing lead implanted
- Life expectancy of < 6 months.
- Known contraindication for physiologic pacing therapy/implant (i.e. ongoing infection, known occlusion of the subclavian vein, etc.).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03719040
Contact: Jemy C Allen | +1 972-309-8503 | jemymah.allen@abbott.com | |
Contact: Anuja Kulkarni | +1 408-845-8275 | anuja.kulkarni@abbott.com |

Study Director: | Clay Cohorn | Abbott |
Responsible Party: | Abbott Medical Devices |
ClinicalTrials.gov Identifier: | NCT03719040 |
Other Study ID Numbers: |
ABT-CIP-10270 |
First Posted: | October 25, 2018 Key Record Dates |
Last Update Posted: | July 16, 2020 |
Last Verified: | July 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Syncope Cardiomyopathies Tachycardia Tachycardia, Ventricular Bradycardia Heart Block Sick Sinus Syndrome Heart Diseases Cardiovascular Diseases |
Arrhythmias, Cardiac Cardiac Conduction System Disease Pathologic Processes Unconsciousness Consciousness Disorders Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Arrhythmia, Sinus |